More from the 2012 AACR Meeting – The Impact of Curcumin plus Docetaxil in Castrate Resistant Prostate Cancer

Curcumin is thought to have anti-cancer activity as well as to provide a synergistic effect with chemotherapy agents. Because of this Dr. Eloise Planchat of the Centre Jean Perrin, Division de Recherche Clinique, EA4231, Université d’Auvergne shared results from a prospective phase II study that assessed the impact of the combination of docetaxel (chemotherapy) plus [...]

From The AACR 2012 Meeting – Does Lycopene Effect Prostate Cancer?

From The AACR 2012 Meeting - Does Lycopene Effect Prostate Cancer? Yesterday’s post was about the themes I saw in cancer research. Starting today I will be reporting specific research items I saw at the meeting that specifically are important to men with prostate cancer. Dr. Peter Gann of the University of Illinois at Chicago [...]

Some Important Themes From The 2012 AACR Meeting

Last week I had the privilege of attending the Annual 2012 American Association of Cancer Researchers (AACR) in Chicago through the generosity of the Scientist-Survivor Program. The meeting involved five days of educational sessions, symposia and posters. In the course of the next week or so, I will be discussing some of the prostate cancer [...]

By |2017-10-19T10:51:14-04:00April 10th, 2012|AACR, Advanced Prostate Cancer, Research, Uncategorized|0 Comments
Go to Top